Empowered Funds’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Sell |
10,689
-1,366
| -11% | -$172K | 0.02% | 978 |
|
|
2025
Q1 | $1.33M | Buy |
+12,055
| New | +$1.33M | 0.02% | 903 |
|
|
2024
Q4 | – | Sell |
-62,052
| Closed | -$7.15M | – | 1713 |
|
|
2024
Q3 | $7.15M | Buy |
62,052
+54,114
| +682% | +$6.24M | 0.11% | 259 |
|
|
2024
Q2 | $1.09M | Buy |
7,938
+111
| +1% | +$15.3K | 0.02% | 834 |
|
|
2024
Q1 | $1.08M | Sell |
7,827
-13,211
| -63% | -$1.82M | 0.02% | 840 |
|
|
2023
Q4 | $2.77M | Sell |
21,038
-16,622
| -44% | -$2.19M | 0.07% | 406 |
|
|
2023
Q3 | $4.24M | Buy |
37,660
+20,651
| +121% | +$2.32M | 0.12% | 215 |
|
|
2023
Q2 | $1.6M | Buy |
17,009
+8,636
| +103% | +$814K | 0.06% | 485 |
|
|
2023
Q1 | $848K | Buy |
+8,373
| New | +$848K | 0.05% | 313 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 376 |
|